Therapy of experimental babesiosis

K. S. Rowin, H. B. Tanowitz, M. Wittner

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Babesia microti infections established in hamsters were treated successfully with clindamycin. Regimens that contained this drug consistently cleared the infection rapidly and without relapse once the drug was discontinued. Late in the course of the infection, the addition of quinine, through the oral but not parenteral route, to clindamycin therapy, was more effective than clindamycin alone. Both clindamycin and the combination of clindamycin and oral quinine are safe, effective treatment for life-threatening babesiosis.

Original languageEnglish (US)
Pages (from-to)556-558
Number of pages3
JournalAnnals of Internal Medicine
Volume97
Issue number4
StatePublished - 1982

Fingerprint

Babesiosis
Investigational Therapies
Clindamycin
Quinine
Babesia microti
Infection
Cricetinae
Pharmaceutical Preparations
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rowin, K. S., Tanowitz, H. B., & Wittner, M. (1982). Therapy of experimental babesiosis. Annals of Internal Medicine, 97(4), 556-558.

Therapy of experimental babesiosis. / Rowin, K. S.; Tanowitz, H. B.; Wittner, M.

In: Annals of Internal Medicine, Vol. 97, No. 4, 1982, p. 556-558.

Research output: Contribution to journalArticle

Rowin, KS, Tanowitz, HB & Wittner, M 1982, 'Therapy of experimental babesiosis', Annals of Internal Medicine, vol. 97, no. 4, pp. 556-558.
Rowin KS, Tanowitz HB, Wittner M. Therapy of experimental babesiosis. Annals of Internal Medicine. 1982;97(4):556-558.
Rowin, K. S. ; Tanowitz, H. B. ; Wittner, M. / Therapy of experimental babesiosis. In: Annals of Internal Medicine. 1982 ; Vol. 97, No. 4. pp. 556-558.
@article{abaab3e25b0e4a4eb7c795b530237139,
title = "Therapy of experimental babesiosis",
abstract = "Babesia microti infections established in hamsters were treated successfully with clindamycin. Regimens that contained this drug consistently cleared the infection rapidly and without relapse once the drug was discontinued. Late in the course of the infection, the addition of quinine, through the oral but not parenteral route, to clindamycin therapy, was more effective than clindamycin alone. Both clindamycin and the combination of clindamycin and oral quinine are safe, effective treatment for life-threatening babesiosis.",
author = "Rowin, {K. S.} and Tanowitz, {H. B.} and M. Wittner",
year = "1982",
language = "English (US)",
volume = "97",
pages = "556--558",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "4",

}

TY - JOUR

T1 - Therapy of experimental babesiosis

AU - Rowin, K. S.

AU - Tanowitz, H. B.

AU - Wittner, M.

PY - 1982

Y1 - 1982

N2 - Babesia microti infections established in hamsters were treated successfully with clindamycin. Regimens that contained this drug consistently cleared the infection rapidly and without relapse once the drug was discontinued. Late in the course of the infection, the addition of quinine, through the oral but not parenteral route, to clindamycin therapy, was more effective than clindamycin alone. Both clindamycin and the combination of clindamycin and oral quinine are safe, effective treatment for life-threatening babesiosis.

AB - Babesia microti infections established in hamsters were treated successfully with clindamycin. Regimens that contained this drug consistently cleared the infection rapidly and without relapse once the drug was discontinued. Late in the course of the infection, the addition of quinine, through the oral but not parenteral route, to clindamycin therapy, was more effective than clindamycin alone. Both clindamycin and the combination of clindamycin and oral quinine are safe, effective treatment for life-threatening babesiosis.

UR - http://www.scopus.com/inward/record.url?scp=0019932528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019932528&partnerID=8YFLogxK

M3 - Article

C2 - 7125412

AN - SCOPUS:0019932528

VL - 97

SP - 556

EP - 558

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 4

ER -